Reunion Neuroscience
Phase 2Reunion Neuroscience is a clinical stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.
Founded
2020
Focus
Psychedelics
About
Reunion Neuroscience is a clinical stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.
Funding History
2Total raised: $37M
Series A$25MNovamindAug 15, 2022
Seed$12MField Trip HealthFeb 15, 2021
Company Info
TypePrivate
Founded2020
LocationToronto, United States
StagePhase 2
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile